OCS — OCULIS HOLDING AG

Ownership history in SYQUANT CAPITAL SAS  ·  1 quarter on record

This page tracks every 13F SEC filing in which SYQUANT CAPITAL SAS reported a position in OCULIS HOLDING AG (OCS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.47% (2025 Q4)
Avg. % of fund
0.47%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 192,722 — — 0.47% $3.8M $19.97
% of Fund (quarterly)    OCS price (monthly, adj. close)

Other funds also holding OCS

As of 2025 Q4 — sorted by position size

Pivotal bioVenture Partners Investment Advisor LLC 3Y 17.67% Nan Fung Group Holdings Ltd 3Y 9.2% Propel Bio Management, LLC 2.95% Saturn V Capital Management LP 3Y 1.89% SR ONE CAPITAL MANAGEMENT, LP 3Y 1.81% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.38% Neo Ivy Capital Management 3Y 7Y 0.4% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.18% FOLKETRYGDFONDET 3Y 7Y 0.08% Aberdeen Group plc 3Y 7Y 0.05%
← Back to SYQUANT CAPITAL SAS Holdings